Multi-domain Versus Uni-Domain Training on Executive Control and Memory Functions of Older Adults
NCT03823183, Not applicable, Unknown, Universidad Nacional de Educación a Distancia
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Multi-domain Versus Uni-Domain Training on Executive Control and Memory Functions of Older Adults | ClinicalTrials.gov |
| NCT number | NCT03823183 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 120 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Universidad Nacional de Educación a Distancia | ClinicalTrials.gov |
| Conditions | Executive Functions, Memory Functions | ClinicalTrials.gov |
| Interventions | Cognitive training, Physical training, Cognitive control, Physical control | ClinicalTrials.gov |
| First posted | 2019-01-30 | ClinicalTrials.gov |
| Last updated | 2019-02-01 | ClinicalTrials.gov |
Registered outcomes 16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Executive functions assessed with Memory-based Task Switching | Change from Baseline in Memory-based Task Switching to 3 and 6 months | Reaction time (RT) of correct responses in Memory-based Task Switching | ClinicalTrials.gov |
| Primary | Executive functions assessed with Memory-based Task Switching | Change from Baseline in Memory-based Task Switching to 3 and 6 months | Performance in the Memory-base Task Switching: Neurophysiological parameter-Event-related potentials (ERPs) in the Memory-Based Task Switching | ClinicalTrials.gov |
| Primary | Attention assessed with Trail Making Test A+B | Change from Baseline in Trail Making Test to 3 and 6 months | Performance in Trail Making Test A+B score | ClinicalTrials.gov |
| Primary | Inhibition assessed with Stroop Task | Change from Baseline in Stroop Task to 3 and 6 months | Reaction time (RT) of correct responses in the Stroop Task | ClinicalTrials.gov |
| Primary | Working memory assessed with the N-back Task | Change from Baseline in the N-Back Task to 3 and 6 months | Hits-False Alarms in the N-back Task | ClinicalTrials.gov |
| Primary | Immediate visual memory assessed with Visual Memory Face I (Weschler Memory Scale) | Change from Baseline in Face I to 3 and 6 months | Units on the Scale: scale range (minimum score = 0 and maximum score = 48). | ClinicalTrials.gov |
| Primary | Differed visual memory assessed with Visual Memory Face II (Weschler Memory Scale) | Change from Baseline in Face II to 3 and 6 months | Units on the Scale: scale range (minimum score = 0 and maximum score = 48). With data from Visual Memory Face I (inmediate recognition) and Visual Memory Face II (differed recognition) we compute the percentage of memory retention = Visual Memory Face II / Visual Memory Face I X 100 | ClinicalTrials.gov |
| Primary | Immediate verbal memory assessed with Pair-Words I (Weschler Memory Scale) | Change from Baseline in Pair-Words I to 3 and 6 months | Units on the Scale: scale range for Recall (minimum score = 0 and maximum score = 32). | ClinicalTrials.gov |
| Primary | Differed verbal memory assessed with Pair-Words II (Weschler Memory Scale) | Change from Baseline in Pair-Words II to 3 and 6 months | Units on the Scale: scale range for Recall (minimum score = 0 and maximum score = 8). scale range for Recognition (minimum score =0 and maximum score = 24) Recall. With data from Pair-Words I (inmediate recognition) and Pair-Words II (differed recognition) we compute the percentage of memory retention = Pair-Words II / Pair-Word I X 100 | ClinicalTrials.gov |
| Secondary | Emotional and affective wellbeing assessed with Positive and Negative Affect Schedule (PANAS) | Change from Baseline in PANAS to 3 and 6 months | Units on the Scale: 20 items Each item is evaluated between 0 (nothing) and 5 (many). Positive emotions are assessed with items: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19. Negative emotions are assessed with items: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20. | ClinicalTrials.gov |
| Secondary | Emotional and affective wellbeing assessed with The Life Satisfaction Index (LSI): 20 items Each item is assessed using two-point agree/disagree score rated items 0 for a response indicating dissatisfaction and 1 for satisfaction. | Change from Baseline in LSI to 3 and 6 months | Units on the Scale: 20 items A two-point agree/disagree score rated items 0 for a response indicating dissatisfaction and 1 for satisfaction. | ClinicalTrials.gov |
| Secondary | Cardio-respiratory capacity assessed with the 6 Minutes Walk Test | Change from Baseline in 6 Minutes Walk Test to 3 and 6 months | Physiological parameter | ClinicalTrials.gov |
| Secondary | Physical dimension assessed with The Short Physical Performance Battery (SPPB) | Change from Baseline in SPPB to 3 and 6 months | Units on the Scale | ClinicalTrials.gov |
| Secondary | Demographic interview and medical history | Baseline | Respond to questions related to demographics and medical history | ClinicalTrials.gov |
| Secondary | General cognitive state assessed with Mini Mental State Examination (MMSE) | Baseline | Units on the test: scale range (minimum score = 0 and maximum score = 30). Values between 27 and 30 points are considered as "appropriate cognitive state". Values between 24 and 26 points are considered as "possible mild cognitive impairment" Values between 0 and 23 points are considered as "possible dementia". This test is a screening test and it is not adequate to diagnose. In this protocol participants with scores under 27 will be excluded from the study. | ClinicalTrials.gov |
| Secondary | General depression state assessed with Yesavage Abbreviate Questionnaire. (GDS) | Baseline | Units on the test: scale range (minimum score = 0 and maximum score = 15). Values between 0 and 5 points are considered as "no depression". Values between 5 and 10 points are considered as "mild depression" Values between 10 and 15 points are considered as "severe depression". This test is a screening test and it is not adequate to diagnose. In this protocol participants with scores greater than 5 will be excluded from the study. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 32410715 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| 1-Back Task | Primary outcome | ConductCognition |
| 2-Back Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Task Switching Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)